PT - JOURNAL ARTICLE AU - Somadina I Okwelogu AU - Joseph I Ikechebelu AU - Nneka R Agbakoba AU - Kingsley C Anukam TI - Microbiota compositions from infertile couples seeking <em>in vitro</em> fertilization (IVF), using 16S rRNA gene sequencing methods: any correlation to clinical outcomes? AID - 10.1101/2020.10.22.20215988 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.22.20215988 4099 - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20215988.short 4100 - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20215988.full AB - Bacterial infections are usually suspected in infertile couples seeking IVF with no clear understanding of the microbial compositions present in the seminal fluids and vaginal swabs of the patients. We used next-generation sequencing technology to correlate microbiota compositions with IVF clinical outcomes. Thirty-six couples were recruited to provide seminal fluids and vaginal swabs. Seminal fluid microbiota compositions had lower bacterial concentrations compared with the vagina, but species diversity was significantly higher in seminal fluid samples. Azoospermic subjects had more relative abundance of Mycoplasma and Ureaplasma. In Normospermic semen Lactobacillus (43.86%) was the most abundant, followed by Gardnerella (25.45%), while the corresponding vaginal samples, Lactobacillus (61.74%) was the most abundant, followed by Prevotella (6.07%), and Gardnerella (5.86%). Semen samples with positive IVF were significantly colonized by Lactobacillus jensenii (P=0.002), Faecalibacterium (P=0.042) and significantly less colonized by Proteobacteria, Prevotella, Bacteroides and lower Firmicutes/Bacteroidetes ratio compared with semen samples with negative IVF. Vaginal samples with positive IVF clinical outcome were significantly colonized by Lactobacillus gasseri, less colonized by Bacteroides, and Lactobacillus iners. This study has opened a window of possibility for Lactobacillus replenishments in men and women prior to IVF treatment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAcknowledgements We would like to acknowledge uBiome Inc., San Francisco, California, USA, for assisting in the 16S rRNA metagenomics sequencing under an academic consortium grant-in-kind award to Dr. Kingsley Anukam. However, uBiome did not participate in the design of the study, collection, analysis, interpretation of data and in writing the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval The study was approved by the Ethics Review Committee on Human Research from Nnamdi Azikiwe University Teaching Hospital (Ref # NAUTH/CS/66/VOL11/175/2018/111). Participation in the study was voluntary. Informed written consent was obtained from the patients. All methods were performed in accordance with the relevant guidelines and regulations. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailability of data and materials The datasets used and or analyzed in the current study are available from the corresponding author on reasonable request.